umu.sePublications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Phase 2 open-label extension study of patisiran, an investigational RNAi therapeutic for the treatment of familial amyloid polyneuropathy
Umeå University, Faculty of Medicine, Department of Public Health and Clinical Medicine, Medicine.
Show others and affiliations
2015 (English)In: Journal of Neurology, Neurosurgery and Psychiatry, ISSN 0022-3050, E-ISSN 1468-330X, Vol. 86, no 11Article in journal, Meeting abstract (Other academic) Published
Resource type
Text
Place, publisher, year, edition, pages
2015. Vol. 86, no 11
National Category
Neurology
Identifiers
URN: urn:nbn:se:umu:diva-112659DOI: 10.1136/jnnp-2015-312379.27ISI: 000364994100028OAI: oai:DiVA.org:umu-112659DiVA: diva2:881900
Conference
Annual Meeting of the Association-of-British-Neurologists (ABN), SEP 10, 2015, Inst Educ, London, ENGLAND
Available from: 2015-12-11 Created: 2015-12-11 Last updated: 2016-01-21Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full text

Search in DiVA

By author/editor
Suhr, Ole
By organisation
Medicine
In the same journal
Journal of Neurology, Neurosurgery and Psychiatry
Neurology

Search outside of DiVA

GoogleGoogle Scholar

Altmetric score

Total: 104 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf